Segment Reporting - Additional Information (Detail)	3 Months Ended		12 Months Ended
	Mar. 31, 2022 USD ($) Segment	Mar. 31, 2021 USD ($)	Dec. 31, 2021
Number of operating segments | Segment	1
Revenue	$ 206,400,000	$ 142,837,000
Sales Revenue
Revenue		$ 0
Customer Concentration Risk | Pfizer [Member]
Revenue	$ 21,100,000
Customer Concentration Risk | Sales Revenue | Minimum [Member]
Accounts receivable, percentage by customer		10.00%
Customer Concentration Risk | Sales Revenue | Pfizer [Member]
Accounts receivable, percentage by customer	10.00%
Customer Concentration Risk | Accounts Receivable [Member] | Pfizer [Member]
Accounts receivable, percentage by customer			14.00%
Customer Concentration Risk | Accounts Receivable [Member] | Customer Number One [Member]
Accounts receivable, percentage by customer	10.00%
Customer Concentration Risk | Total Trade Accounts Receivable Royalties And Other Receivables | Pfizer [Member]
Accounts receivable, percentage by customer			10.00%